China No1 for outsourcing, says PwC
China is the ideal destination for outsourcing, according to a report by PricewaterhouseCoopers (PwC) that has calculated rankings based on a range of parameters.
China is the ideal destination for outsourcing, according to a report by PricewaterhouseCoopers (PwC) that has calculated rankings based on a range of parameters.
US CRO group Encorium has signed new contracts worth around $6.2m (€4.1m) under which it will conduct trials of a developmental vaccine on behalf of a global biopharmaceutical company.
Ion channel expert ChanTest is expanding its range of ion channel services and cell lines that help identify promising target compounds and those that could cause harmful side effects.
in-PharmaTechnologist.com presents its latest round-up of personnel changes in the pharmaceutical sector.
Phylogeny has launched the first microRNA (miRNA) in situ hybridisation detection service to help scientists delve deeper into the mechanisms controlling key biological processes.
Sanofi-Aventis’ €1.8bn ($2.6bn) offer for Czech generics firm Zentiva has been unanimously accepted by the latter firm’s board after four months of wrangling that has seen the bid increase by 9.5 per cent.
The WHO has issued Sandoz with a Notice of Concern (NoC) after an inspection of the firm’s Kempton Park facility in South Africa identified 41 deviations from GMP standards.
The US Food and Drug Administration (FDA) has issued draft guidance for the use of genetically engineered (GE) animals to produce drugs.